- 1) Imazu, M., Hypertension and insulin disorders. Curr. Hypertens. Rep., 4, 477–482 (2002).
- 2) Karaki, H., Doi, K., and Sugano, S., Antihypertensive effect of tryptic hydrolyzate of milk casein in spontaneously hypertensive rats. Comp. Biochem. Physiol., 96, 367–371 (1990).
- 3) Yoshikawa, M., Fujita, H., and Matoba, N., Bioactive peptides derived from food proteins preventing lifestyle-related diseases. Biofactors, 12, 143–146 (2000).
- 4) Fujita, H., Yokoyama, K., and Yoshikawa, M., Classification and antihypertensive activity of angiotensin I-converting enzyme inhibitory peptides derived from food proteins. J. Food Sci., 65, 564–569 (2000).
- 5) Arai, S., Osawa, T., and Ohigashi, H., A mainstay of functional food science in Japan: history, present status, and future outlook. Biosci. Biotechnol. Biochem., 65, 1–13 (2001).
- 6) Pappenheimer, J. R., Dahl, C. E., and Karnovsky, M. L., Intestinal absorption and excretion of octapeptides composed of D-amino acids. Proc. Natl. Acad. Sci. USA, 91, 1942–1945 (1994).
- 7) Adson, A., Raub, T. J., and Burton, P. S., Quantitative approaches to declineate paracellular diffusion in cultured epithelial cell monolayers. J. Pharm. Sci., 83, 1529–1536 (1994).
- 8) Shimizu, M., Tsunogai, M., and Arai, S., Transepithelial transport of oligopeptides in the human intestinal cell, Caco-2. Peptides, 18, 681–687 (1997).
- 9) Sai, M., Kajita, M., and Tamai, I., Adsorptive-mediated endocytosis of a basic peptide in erythrocyte-like Caco-2 cells. Am. J. Physiol., 275, 514–520 (1998).
- 10) Fei, Y. J., Kanai, Y., and Nussberger, S., Expression cloning of a mammalian proton-coupled oligopeptides transporter. Nature, 368, 563–566 (1994).
- 11) Liang, R., Fei, Y. J., and Prasad, P. D., Human intestinal H+/peptide cotransporter. J. Biol. Chem., 270, 6456–6463 (1995).
- 12) Liu, D., Sun, H. Y., and Zhang, L. J., High-level expression of milk-derived AHP in Escherichia coli and its bioactivity. J. Agric. Food Chem., 55, 5109–5112 (2007).
- 13) Hidalgo, I. J., Raub, T. J., and Borchardt, R. T., Characterization of the human colon carcinoma cell line (Caco-2) as a model system for intestinal epithelial permeability. Gastroenterology, 96, 736–749 (1989).
- 14) Artursson, P., Palm, K., and Luthman, K., Caco-2 monolayers in experimental and theoretical predictions of drug transport. Drug Deliv. Rev., 46, 27–43 (2001).
- 15) Zhu, X. L., Matsui, T., Watanabe, K., Shiraishi, K., Ueki, T., and Matsumoto, K., Simultaneous determination of Angiotensin I-converting enzyme inhibitory peptides in tryptic casein hydrolysate by high-performance liquid chromatography combined with a replicate heart-cut column-switching technique. J. Agric. Food Chem., 55, 8367–8371 (2007).
- 16) Irvine, J. D., Takahashi, L., and Lockhart, K., MDCK (Madin-Darby canine kidney) cells: a tool for membrane permeability screening. J. Pharm. Sci., 88, 28–33 (1999).
- 17) Augustijns, P. F., Bradshaw, T. P., and Gan, L. S., Evidence for a polarized efflux system in Caco-2 cells capable of modulating cyclosporin A transport. Biochem. Biophys. Res. Commun., 197, 360–365 (1993).
- 18) Li, H., Chung, S. J., and Kim, D. C., The transport of a reversible proton pump antagonist, 5,6-dimethyl-2-(4-fluorophenylamino)-4-(1-methyl-1,2,3,4-tetrahydroisoquinoline-2-yl) pyrimidine hydrochloride (YH1885), across Caco-2 cell monolayers. Drug Metab. Dispos., 29, 54–59 (2001).
- 19) Matsumoto, S.-I., Saito, H., and Inui, K.-I., Transcellular transport of oral cephalosporins in human intestinal epithelial cells, Caco-2: interaction with dipeptide transport systems in apical and basolateral membranes. J. Pharmacol. Exp. Ther., 270, 498–504 (1994).
- 20) Gan, L. S., Hsyu, P. H., Pritchard, J. F., and Thakker, D. R., Mechanism of intestinal absorption of ranitidine and ondansetron: transport across Caco-2 cell monolayers. Pharm. Res., 10, 1722–1725 (1993).
- 21) Karnes, H. T., Shiu, G., and Shah, V. P., Validation of bioanalytical methods. Pharm. Res., 8, 421–426 (1991).
- 22) Tsuji, A., and Tamai, I., Carrier-mediated intestinal transport of drugs. Pharmcol. Res., 13, 963–977 (1996).
- 23) Artursson, P., and Karlsson, J., Correlation between oral drug absorption in humans and apparent drug permeability coefficients in human intestinal epithelial (Caco-2) cells. Biochem. Biophys. Res. Commun., 175, 880–885 (1991).
- 24) Liao, K., Hoffman, R. D., and Lane, M. D., Phosphotyrosyl turnover in insulin signaling: characterization of two membrane-bound pp15 protein tyrosine phosphatases from 3T3-L1 adipocytes. J. Biol. Chem., 266, 6544–6553 (1991).
- 25) Lo, Y. L., and Huang, J. D., Effects of sodium deoxycholate and sodium caprate on the transport of epirubicin in human intestinal epithelial Caco-2 cell layers and everted gut sacs of rats. Biochem. Pharmacol., 59, 665–672 (2000).
- 26) Richard, A., Walgren, U., Kristina, W., and Thomas, W., Transport of quercetin and its glucosides across human intestinal epithelial Caco-2 cells. Biochem. Pharmacol., 55, 1721–1727 (1998).
- 27) Dyer, J., Beechey, R. B., and Gorvel, J. P., Glycyl-L-Proline transport in rabbit enterocyte basolateral-membrane vesicles. Biochem. J., 269, 565–571 (1990).
- 28) Saito, H., and Inui, K., Dipeptide transporters in apical and basolateral membranes of the human intestinal cell line Caco-2. Am. J. Physiol., 265, 289–294 (1993).
- 29) Enjoh, M., Hashimoto, K., and Arai, S., Inhibitory effect of arphamenine A on intestinal dipeptide transport. Biosci. Biotechnol. Biochem., 60, 1893–1895 (1996).
- 30) Hashimoto, K., and Shimizu, M., Epithelial properties of human intestinal Caco-2 cells cultured in serum-free medium. Cytotechnology, 13, 175–184 (1993).
- 31) Satake, M., Enjoh, M., Nakamura, Y., Takano, T., Kawamura, Y., Arai, S., and Shimizu, M., Transepithelial transport of bioactive tripeptide, Val-Pro-Pro, in human intestinal Caco-2 cell monolayers. Biosci. Biotechnol. Biochem., 66, 378–384 (2002).
- 32) Vermeirssen, V., Deplancke, B., Tappenden, K. A., Vancamp, J., Gaskins, H. R., and Verstraete, W., Intestinal transport of the lactokinin Ala-Leu-Pro-Met-His-Ile-Arg through a Caco-2 bbe monolayer. J. Pept. Sci., 8, 95–100 (2002).
- 33) Quirós, A., Dóvalosb, A., Lasunción, M. A., Ramos, M., and Recio, I., Bioavailability of the antihypertensive peptide LHLPLP: transepithelial flux of HLPLP. Int. Dairy J., 18, 279–286 (2008).
Full access
Transepithelial Transport Characteristics of the Antihypertensive Peptide, Lys-Val-Leu-Pro-Val-Pro, in Human Intestinal Caco-2 Cell Monolayers
Reprints and Corporate Permissions
Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?
To request a reprint or corporate permissions for this article, please click on the relevant link below:
Academic Permissions
Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?
Obtain permissions instantly via Rightslink by clicking on the button below:
If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.